Regeneron Pharmaceuticals Inc at Morgan Stanley Healthcare Conference Transcript
Great. Good morning, everybody. Thanks for joining us for the first session which we'll kick off with Regeneron. I'm Matthew Harrison, one of the biotech analysts here. Before we start, I have to read an important disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley discloses, appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures or you can pick up a copy at the registration desk.
And so with that, we can get down to business. So happy to have with me from Regeneron, Marion McCourt, who runs commercial; and Jay Markowitz, who is SVP of Portfolio Management.
Questions & Answers
So I thought to start off, we would try and just address some of the overriding topics that investors have around Regeneron and then maybe we could spend some time on EYLEA as well as some of the other
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
